Free Trial

Haleon (HLN) Stock Forecast & Price Target

Haleon logo
GBX 328.30 +0.50 (+0.15%)
As of 10/2/2026 12:18 PM Eastern

Haleon - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
2
Hold
1
Buy
2

Based on 5 Wall Street analysts who have issued ratings for Haleon in the last 12 months, the stock has a consensus rating of "Hold." Out of the 5 analysts, 2 have given a sell rating, 1 has given a hold rating, and 2 have given a buy rating for HLN.

Consensus Price Target

GBX 387.80
According to the 5 analysts' twelve-month price targets for Haleon, the average price target is GBX 387.80. The highest price target for HLN is GBX 514, while the lowest price target for HLN is GBX 315. The average price target represents a forecasted upside of 18.12% from the current price of GBX 328.30.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for HLN and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Haleon and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

HLN Analyst Ratings Over Time

TypeCurrent Forecast
10/4/25 to 10/4/26
1 Month Ago
9/4/25 to 9/4/26
3 Months Ago
7/6/25 to 7/6/26
1 Year Ago
10/4/24 to 10/4/25
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
2 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
Sell
2 Sell rating(s)
2 Sell rating(s)
2 Sell rating(s)
1 Sell rating(s)
Consensus Price TargetGBX 387.80GBX 399GBX 393.67GBX 436.67
Consensus RatingHoldHoldHoldHold

HLN Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

HLN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Haleon Stock vs. The Competition

TypeHaleonConsumer Staples Companies
Consensus Rating Score
2.00
2.22
Consensus RatingHoldHold
News Sentiment Rating
Neutral News

See Recent HLN News
Neutral News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
9/9/2026 Lower TargetSellGBX 335 ➝ GBX 320-4.36%
8/11/2026 Boost TargetSector performGBX 370 ➝ GBX 390+6.89%
8/5/2026
Berenberg Bank logo
Berenberg Bank
2 of 5 stars
 Boost TargetBuyGBX 512 ➝ GBX 514+41.02%
7/31/2026 Reiterated RatingBuyGBX 400+8.84%
6/25/2026 Lower TargetUnderweightGBX 335 ➝ GBX 315-9.51%
9/10/2025 Reiterated RatingNeutral ➝ BuyGBX 440+18.44%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 10:28 PM ET.


Should I Buy Haleon Stock? HLN Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Saturday, October 3, 2026. Please send any questions or comments about these Haleon pros and cons to contact@marketbeat.com.

Haleon
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Haleon plc:

  • Haleon plc is currently trading at $328.30, which is significantly below the consensus price target of GBX 399 set by analysts as of September 4, 2026, suggesting potential for substantial upside if the stock reverts to its mean valuation.
  • The company has identified a new growth opportunity in the United States by targeting consumers using GLP-1 weight-loss drugs, placing products that address related side effects in dedicated sections at major retailers like CVS, which could drive incremental sales in a rapidly expanding market segment.
  • Haleon plc recently raised its interim dividend following its first-half 2026 results, signaling management confidence in the company's cash flow generation and providing a steady income stream for investors, supported by a current dividend yield of 2.15%.
  • The stock exhibits a low beta of 0.25, indicating that it is less volatile than the broader market, which may appeal to risk-averse investors seeking stability in their portfolio during periods of market uncertainty.
  • Analysts from Berenberg Bank and Jefferies Financial Group have recently reaffirmed their "buy" ratings with price targets of GBX 514 and GBX 400 respectively, reflecting a bullish view on the company's long-term brand strength and market position despite recent price target adjustments from other firms.

Haleon
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Haleon plc for these reasons:

  • Deutsche Bank Aktiengesellschaft recently lowered its price target on Haleon from GBX 335 to GBX 320 and maintained a "sell" rating, indicating that some institutional investors believe the stock is overvalued relative to its current earnings potential and growth outlook.
  • The company's current ratio of 0.69 and quick ratio of 0.93 suggest that Haleon plc may face short-term liquidity challenges, as its current liabilities exceed its current assets, which could limit its flexibility in managing cash flow obligations.
  • Insider selling activity was observed in March 2026, with Brian McNamara selling a total of 770,000 shares at an average price of GBX 368, which may signal a lack of confidence from company insiders in the stock's near-term performance.
  • The consensus rating for Haleon plc has shifted to "Hold" in recent months, down from "Moderate Buy" earlier in the year, reflecting a more cautious stance among analysts due to concerns about sales growth and competitive pressures in the consumer health sector.
  • Haleon plc's debt-to-equity ratio of 50.38 indicates a moderate level of leverage, which could increase financial risk if interest rates rise or if the company's earnings decline, potentially impacting its ability to service debt and invest in growth initiatives.

HLN Forecast - Frequently Asked Questions

According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for Haleon is GBX 387.80, with a high forecast of GBX 514 and a low forecast of GBX 315.

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Haleon in the last year. There are currently 2 sell ratings, 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" HLN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HLN, but not buy additional shares or sell existing shares.

According to analysts, Haleon's stock has a predicted upside of 18.12% based on their 12-month stock forecasts.

Haleon has been rated by research analysts at Berenberg Bank, Deutsche Bank Aktiengesellschaft, Jefferies Financial Group, and Royal Bank Of Canada in the past 90 days.

Analysts like Haleon less than other "consumer staples" companies. The consensus rating score for Haleon is 2.00 while the average consensus rating score for "consumer staples" companies is 2.22. Learn more on how HLN compares to other companies.


MarketBeat monitors more than a dozen sources for Haleon analyst ratings, with the most recent rating issued on 9/9/2026.
From Our Partners